Giiant Pharma stands out with a unique local delivery strategy to maximize the therapeutic effect at the site of inflammation while minimizing any potential side effects. Potent anti-inflammatory agentsĀ have been engineered to target only the colon by using the Gastrointestinal-induced Anti-inflammatory technology (GiiAnt). In this system, the colon-specific carrier covalently bound to the active moiety is cleaved off locally by the large intestine microbiota.